NO952469L - Terapautisk kombinasjon som inneholder interferon - Google Patents
Terapautisk kombinasjon som inneholder interferonInfo
- Publication number
- NO952469L NO952469L NO952469A NO952469A NO952469L NO 952469 L NO952469 L NO 952469L NO 952469 A NO952469 A NO 952469A NO 952469 A NO952469 A NO 952469A NO 952469 L NO952469 L NO 952469L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic combination
- combination containing
- containing interferon
- human interferon
- combination
- Prior art date
Links
- 102000014150 Interferons Human genes 0.000 title abstract 3
- 108010050904 Interferons Proteins 0.000 title abstract 3
- 229940079322 interferon Drugs 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 229940123457 Free radical scavenger Drugs 0.000 abstract 1
- 238000002648 combination therapy Methods 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 239000002516 radical scavenger Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3476—Powered trocars, e.g. electrosurgical cutting, lasers, powered knives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3494—Trocars; Puncturing needles with safety means for protection against accidental cutting or pricking, e.g. limiting insertion depth, pressure sensors
- A61B17/3496—Protecting sleeves or inner probes; Retractable tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1487—Trocar-like, i.e. devices producing an enlarged transcutaneous opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
- A61B17/3211—Surgical scalpels, knives; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3474—Insufflating needles, e.g. Veress needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/0019—Moving parts vibrating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
- A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Otolaryngology (AREA)
- Plasma & Fusion (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Oppfinnelsen angår en terapeutisk kombinasjon, mer spesifikt en komblnasjonsterapi som Involverer anvendelse av human Interferon. Terapien Innebærer behandling av tilstander som er påvirkelig av be- handling med human Interferon, med en ledsagende fri radikal oppfanger eller forløper eller Induser derav.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226729A GB9226729D0 (en) | 1992-12-22 | 1992-12-22 | Therapeutic combination |
PCT/GB1993/002600 WO1994014473A1 (en) | 1992-12-22 | 1993-12-20 | Therapeutic combination containing interferon |
Publications (2)
Publication Number | Publication Date |
---|---|
NO952469L true NO952469L (no) | 1995-06-20 |
NO952469D0 NO952469D0 (no) | 1995-06-20 |
Family
ID=10727038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952469A NO952469D0 (no) | 1992-12-22 | 1995-06-20 | Terapautisk kombinasjon som inneholder interferon |
Country Status (24)
Country | Link |
---|---|
US (1) | US5830455A (no) |
EP (1) | EP0675730B1 (no) |
JP (2) | JP2849214B2 (no) |
KR (1) | KR100309059B1 (no) |
CN (1) | CN1094642A (no) |
AT (1) | ATE199643T1 (no) |
AU (1) | AU680858B2 (no) |
CA (1) | CA2152389A1 (no) |
DE (1) | DE69330032T2 (no) |
ES (1) | ES2156150T3 (no) |
FR (1) | FR2699407A1 (no) |
GB (1) | GB9226729D0 (no) |
HR (1) | HRP931510A2 (no) |
HU (1) | HUT72965A (no) |
IL (1) | IL108114A (no) |
IT (1) | IT1261949B (no) |
MY (1) | MY141415A (no) |
NO (1) | NO952469D0 (no) |
PL (1) | PL309398A1 (no) |
RU (1) | RU2145235C1 (no) |
TW (1) | TW286283B (no) |
WO (1) | WO1994014473A1 (no) |
YU (1) | YU79393A (no) |
ZA (1) | ZA939583B (no) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
DE4325547C2 (de) * | 1993-07-29 | 1997-11-27 | Max Planck Gesellschaft | Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen |
US6020205A (en) * | 1998-04-10 | 2000-02-01 | Immunosciences Lab, Inc. | Determination of intracellular antioxidant levels |
RU2156134C2 (ru) * | 1998-05-12 | 2000-09-20 | ООО "Формавит" | Биофармацевтический препарат на основе живой культуры bacillus и способ лечения заболевания инфекционной природы |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
NZ547204A (en) | 2000-05-26 | 2008-01-31 | Idenix Cayman Ltd | Methods and compositions for treating flaviviruses and pestiviruses |
WO2002044717A1 (en) * | 2000-12-01 | 2002-06-06 | Cornell Research Foundation | Animal model for flaviviridae infection |
US6759061B2 (en) * | 2001-08-31 | 2004-07-06 | Renew Life, Inc. | Liver function improvement formulation |
AU2002330154A1 (en) * | 2001-09-28 | 2003-04-07 | Centre National De La Recherche Scientifique | Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
EP1450810A4 (en) * | 2001-11-16 | 2005-11-30 | Uab Research Foundation | XANTHINE INHIBITION |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
AU2003248748A1 (en) | 2002-06-28 | 2004-01-19 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
WO2004002999A2 (en) | 2002-06-28 | 2004-01-08 | Idenix (Cayman) Limited | Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
JP2004155777A (ja) * | 2002-10-16 | 2004-06-03 | Asahi Kasei Pharma Kk | C型慢性肝炎治療剤 |
KR20050088079A (ko) | 2002-11-15 | 2005-09-01 | 이데닉스 (케이만) 리미티드 | 2'-분지형 뉴클레오시드 및 플라비비리다에 돌연변이 |
CA2509955A1 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
CA2509687C (en) | 2002-12-12 | 2012-08-14 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
JP2006524227A (ja) * | 2003-03-28 | 2006-10-26 | ファーマセット,インク. | フラビウイルス科ウイルス感染の治療のための化合物 |
CA2734052A1 (en) | 2003-05-30 | 2005-01-13 | Pharmasset, Inc. | Modified fluorinated nucleoside analogues |
JP4731321B2 (ja) * | 2003-07-22 | 2011-07-20 | 協和発酵バイオ株式会社 | ウィルス感染症の予防または治療用組成物 |
PL1658302T3 (pl) | 2003-07-25 | 2011-03-31 | Idenix Pharmaceuticals Inc | Analogi nukleozydów purynowych do leczenia chorób spowodowanych przez Flaviviridae obejmujących zapalenie wątroby typu C |
WO2005018330A1 (en) * | 2003-08-18 | 2005-03-03 | Pharmasset, Inc. | Dosing regimen for flaviviridae therapy |
JP2005104852A (ja) * | 2003-09-29 | 2005-04-21 | Kyowa Hakko Kogyo Co Ltd | モービリウィルス感染症の予防または治療用組成物 |
US7754718B2 (en) | 2004-05-05 | 2010-07-13 | Yale University | Antiviral helioxanthin analogs |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
RU2433124C2 (ru) | 2004-09-14 | 2011-11-10 | Фармассет, Инк. | Способ получения 2'-фтор-2'-алкилзамещенных или других замещенных рибофуранозилпиримидинов и пуринов и их производных |
JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
CU23432B6 (es) | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
JP5254033B2 (ja) | 2005-12-23 | 2013-08-07 | イデニク プハルマセウティカルス,インコーポレイテッド | 分岐型ヌクレオシドを調製するための合成中間体の製造方法 |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
NZ593648A (en) | 2008-12-23 | 2013-09-27 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
CL2009002206A1 (es) | 2008-12-23 | 2011-08-26 | Gilead Pharmasset Llc | Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales. |
EA201100851A1 (ru) | 2008-12-23 | 2012-04-30 | Фармассет, Инк. | Аналоги нуклеозидов |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
BR112012024884A2 (pt) | 2010-03-31 | 2016-10-18 | Gilead Pharmasset Llc | síntese estereosseletiva de ativos contendo fósforo |
US8563530B2 (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate |
US10838095B2 (en) | 2010-08-05 | 2020-11-17 | Pgs Geophysical As | Wavefield deghosting of seismic data recorded using multiple seismic sources at different water depths |
AR084044A1 (es) | 2010-11-30 | 2013-04-17 | Pharmasset Inc | Compuestos 2’-espiro-nucleosidos |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
US8809354B2 (en) | 2011-12-31 | 2014-08-19 | Sheikh Riazuddin | 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
ES2792503T3 (es) | 2013-08-27 | 2020-11-11 | Gilead Pharmasset Llc | Formulación combinada de dos compuestos antivirales |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526205A (en) * | 1974-11-07 | 1978-09-27 | Searle & Co | Treatment of interferon-like material |
US4100150A (en) * | 1975-11-04 | 1978-07-11 | G. D. Searle & Co. | Stabilization of interferon against mechanical stress using thioctic acid |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
CH666814A5 (it) * | 1986-07-24 | 1988-08-31 | Inpharzam Int Sa | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. |
CA1321349C (en) * | 1986-11-21 | 1993-08-17 | Robert Zimmerman | Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
US4985241A (en) * | 1986-11-21 | 1991-01-15 | Cetus Corporation | Therapeutic combination of free-radical scavenger and tumor necrosis factor |
IT1231012B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Composizione farmaceutica per uso orale contenente nac. |
US5248697A (en) * | 1990-09-20 | 1993-09-28 | Brigham And Women's Hospital | Enhancement of glutathione levels with glutamine |
ATE134002T1 (de) * | 1990-11-19 | 1996-02-15 | Manz Galvano Technik Gmbh | Sperr- und dränagevorrichtung für tauchtrommeln bei der galvanischen und/oder chemischen oberflächenbehandlung von massenteilen |
-
1992
- 1992-12-22 GB GB929226729A patent/GB9226729D0/en active Pending
-
1993
- 1993-04-12 TW TW082102718A patent/TW286283B/zh active
- 1993-12-20 ES ES94902910T patent/ES2156150T3/es not_active Expired - Lifetime
- 1993-12-20 HU HU9501841A patent/HUT72965A/hu unknown
- 1993-12-20 CA CA002152389A patent/CA2152389A1/en not_active Abandoned
- 1993-12-20 KR KR1019950702659A patent/KR100309059B1/ko not_active IP Right Cessation
- 1993-12-20 DE DE69330032T patent/DE69330032T2/de not_active Expired - Fee Related
- 1993-12-20 WO PCT/GB1993/002600 patent/WO1994014473A1/en active IP Right Grant
- 1993-12-20 AU AU57076/94A patent/AU680858B2/en not_active Ceased
- 1993-12-20 RU RU95113492A patent/RU2145235C1/ru active
- 1993-12-20 PL PL93309398A patent/PL309398A1/xx unknown
- 1993-12-20 EP EP94902910A patent/EP0675730B1/en not_active Expired - Lifetime
- 1993-12-20 AT AT94902910T patent/ATE199643T1/de not_active IP Right Cessation
- 1993-12-20 YU YU79393A patent/YU79393A/sh unknown
- 1993-12-20 JP JP6514930A patent/JP2849214B2/ja not_active Expired - Lifetime
- 1993-12-21 CN CN93121281A patent/CN1094642A/zh active Pending
- 1993-12-21 FR FR9315349A patent/FR2699407A1/fr active Pending
- 1993-12-21 ZA ZA939583A patent/ZA939583B/xx unknown
- 1993-12-21 MY MYPI93002794A patent/MY141415A/en unknown
- 1993-12-21 HR HR931510A patent/HRP931510A2/hr not_active Application Discontinuation
- 1993-12-21 IL IL10811493A patent/IL108114A/en active IP Right Grant
- 1993-12-21 JP JP5322685A patent/JPH06234657A/ja active Pending
- 1993-12-21 IT ITRM930840A patent/IT1261949B/it active IP Right Grant
-
1995
- 1995-06-20 NO NO952469A patent/NO952469D0/no not_active Application Discontinuation
-
1996
- 1996-09-06 US US08/706,645 patent/US5830455A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
TW286283B (no) | 1996-09-21 |
RU2145235C1 (ru) | 2000-02-10 |
CN1094642A (zh) | 1994-11-09 |
ZA939583B (en) | 1995-05-22 |
US5830455A (en) | 1998-11-03 |
JPH08504799A (ja) | 1996-05-21 |
YU79393A (sh) | 1996-10-09 |
IL108114A0 (en) | 1994-04-12 |
ES2156150T3 (es) | 2001-06-16 |
IT1261949B (it) | 1996-06-04 |
DE69330032D1 (de) | 2001-04-19 |
CA2152389A1 (en) | 1994-07-07 |
HU9501841D0 (en) | 1995-08-28 |
AU680858B2 (en) | 1997-08-14 |
HRP931510A2 (en) | 1995-12-31 |
KR100309059B1 (ko) | 2002-06-20 |
PL309398A1 (en) | 1995-10-02 |
GB9226729D0 (en) | 1993-02-17 |
DE69330032T2 (de) | 2001-09-06 |
ITRM930840A0 (it) | 1993-12-21 |
ATE199643T1 (de) | 2001-03-15 |
AU5707694A (en) | 1994-07-19 |
FR2699407A1 (fr) | 1994-06-24 |
NO952469D0 (no) | 1995-06-20 |
HUT72965A (en) | 1996-06-28 |
JP2849214B2 (ja) | 1999-01-20 |
JPH06234657A (ja) | 1994-08-23 |
IL108114A (en) | 1999-12-31 |
MY141415A (en) | 2010-04-30 |
ITRM930840A1 (it) | 1995-06-21 |
WO1994014473A1 (en) | 1994-07-07 |
EP0675730B1 (en) | 2001-03-14 |
EP0675730A1 (en) | 1995-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO952469L (no) | Terapautisk kombinasjon som inneholder interferon | |
PT858343E (pt) | Terapia por infusao continua de uma dose baixa de citoquina | |
BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
SE8704298D0 (sv) | Compounds for use in therapy | |
ATE289508T1 (de) | Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom | |
SG17493G (en) | Ozone decontamination of blood and blood products | |
NO20032027D0 (no) | Effektive antitumorbehandlinger | |
DE68912155D1 (de) | Antivirales Kombinationspräparat. | |
ES2139674T3 (es) | Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio. | |
SE9601396D0 (sv) | New therapeutic treatment 2 | |
ATE76579T1 (de) | Interferon-zusammensetzungen. | |
FI944236A (fi) | Migreenin hoitomenetelmä | |
NO970573D0 (no) | Ylidenforbindelser og deres fremstilling | |
DE69924979D1 (de) | Behandlung von chronischen schmerzen | |
ATE204760T1 (de) | Verwendung von thymosin zur behandlung von hepatitis c bei patienten, die auf interferongaben nicht ansprechen | |
NO995539D0 (no) | Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer | |
ES2058555T3 (es) | Medicamento para el tratamiento intralesional del carcinoma de celulas escamosas, con alfa-interferon humano recombinante. | |
IT8020678A0 (it) | Agente terapeutico per il trattamento del reumatismo. | |
DK0788355T3 (da) | Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme | |
RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) | |
IT8322369A0 (it) | Applicazione terapeutica delmazindolo nel trattamento delrussamento. | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |